title: Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial.
abstract: OBJECTIVE
  To investigate whether acupuncture is superior to placebo and equivalent to sumatriptan for the early treatment of an acute migraine attack.
  
  
  METHODS
  Randomized, partly double-blind (sumatriptan versus placebo) trial.
  
  
  METHODS
  Two hospitals in Germany (one specialized in traditional Chinese medicine and one in the treatment of headache).
  
  
  METHODS
  A total of 179 migraineurs experiencing the first symptoms of a developing migraine attack.
  
  
  METHODS
  Traditional Chinese acupuncture, sumatriptan (6 mg subcutaneously) or placebo injection.
  
  
  METHODS
  Number of patients in whom a full migraine attack (defined as severe migraine headache) within 48 h was prevented. In patients who developed a migraine attack in spite of early treatment, acupuncture and sumatriptan were applied a second time, whilst patients initially randomized to placebo received sumatriptan.
  
  
  RESULTS
  A full migraine attack was prevented in 21 of 60 (35%) patients receiving acupuncture, 21 of 58 (36%) patients receiving sumatriptan and 11 of 61 (18%) patients receiving placebo (relative risk of having a full attack 0.79 (95% CI, 0.64-0.99) for acupuncture versus placebo, and 0.78 (95% CI, 0.62-0.98) for sumatriptan versus placebo). Response to the second intervention in patients who developed a full attack was better with sumatriptan (17/31 patients who received sumatriptan twice and 37/46 patients who had had placebo first) than with acupuncture (4/31). The number of patients reporting side-effects was 14 in the acupuncture group, 23 in the sumatriptan group and 10 in the placebo group.
  
  
  CONCLUSIONS
  In this trial acupuncture and sumatriptan were more effective than a placebo injection in the early treatment of an acute migraine attack. When an attack could not be prevented, sumatriptan was more effective than acupuncture at relieving headache.
authors.affiliation: Department of Internal Medicine II, Center for Complementary Medicine Research, Technical University, Kaiserstrasse 9, 80801 Munich, Germany. dieter.melchart@lrz.tu-muenchen.de
authors.forename: D
authors.initials: D
authors.lastname: Melchart
authors.forename: J
authors.initials: J
authors.lastname: Thormaehlen
authors.forename: S
authors.initials: S
authors.lastname: Hager
authors.forename: J
authors.initials: J
authors.lastname: Liao
authors.forename: K
authors.initials: K
authors.lastname: Linde
authors.forename: W
authors.initials: W
authors.lastname: Weidenhammer
mesh_terms: D015670:Acupuncture Therapy / Q000379:methods*; D000328:Adult; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000628:therapy*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D018170:Sumatriptan / Q000627:therapeutic use*; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D017366:Serotonin Receptor Agonists; D018170:Sumatriptan